Javanmardifard Z, Rahmani S, Bayat H, Mirtavoos-Mahyari H, Ghanei M, Mowla S
Front Genet. 2024; 15:1419099.
PMID: 39381140
PMC: 11460580.
DOI: 10.3389/fgene.2024.1419099.
Chen G, Wang Y, Zhang L, Yang K, Wang X, Chen X
BMC Nephrol. 2024; 25(1):252.
PMID: 39112935
PMC: 11308398.
DOI: 10.1186/s12882-024-03688-7.
Azam H, Rossling R, Geithe C, Khan M, Dinter F, Hanack K
Front Mol Neurosci. 2024; 17:1386735.
PMID: 38883980
PMC: 11177777.
DOI: 10.3389/fnmol.2024.1386735.
Metcalf G
Oncogene. 2024; 43(28):2135-2142.
PMID: 38839942
PMC: 11226400.
DOI: 10.1038/s41388-024-03076-3.
Garmaa G, Bunduc S, Koi T, Hegyi P, Csupor D, Ganbat D
Noncoding RNA. 2024; 10(3).
PMID: 38804362
PMC: 11130806.
DOI: 10.3390/ncrna10030030.
Preanalytical considerations for clinical assays of circulating human miRNA-451a, miRNA-423-5p and miRNA-199a-3p for diagnostic purposes.
Chandel D, Tom W, Jiang C, Krzyzanowski G, Fernando N, Olou A
PLoS One. 2024; 19(5):e0303598.
PMID: 38768135
PMC: 11104614.
DOI: 10.1371/journal.pone.0303598.
MicroRNAs as Potential Graft Rejection or Tolerance Biomarkers and Their Dilemma in Clinical Routines Behaving like Devilish, Angelic, or Frightening Elements.
Legaz I, Jimenez-Coll V, Gonzalez-Lopez R, Fernandez-Gonzalez M, Alegria-Marcos M, Galian J
Biomedicines. 2024; 12(1).
PMID: 38255221
PMC: 10813128.
DOI: 10.3390/biomedicines12010116.
Functional and Potential Therapeutic Implication of MicroRNAs in Pancreatic Cancer.
Pal A, Ojha A, Ju J
Int J Mol Sci. 2023; 24(24).
PMID: 38139352
PMC: 10744132.
DOI: 10.3390/ijms242417523.
Canine urothelial carcinoma: a pilot study of microRNA detection in formalin-fixed, paraffin-embedded tissue samples and in normal urine.
Varvil M, Clark S, Bailey T, Ramos-Vara J, Dos Santos A
J Vet Diagn Invest. 2023; 36(1):70-77.
PMID: 38014733
PMC: 10734577.
DOI: 10.1177/10406387231211908.
MicroRNA Landscape in Endometrial Carcinomas in an Asian population: Unraveling Subtype-Specific Signatures.
Tan G, Leong S, Jin Y, Kuick C, Chee J, Low S
Cancers (Basel). 2023; 15(21).
PMID: 37958433
PMC: 10648581.
DOI: 10.3390/cancers15215260.
Relevance of micro-RNAs and their targets as a diagnostic and prognostic marker in oral squamous cell carcinoma.
Thomas P, Preethi K, Selvakumar S, Ramani P, Sekar D
J Oral Maxillofac Pathol. 2023; 27(2):364-373.
PMID: 37854932
PMC: 10581285.
DOI: 10.4103/jomfp.jomfp_349_22.
Archival skin biopsy specimens as a tool for miRNA-based diagnosis: Technical and post-analytical considerations.
Andelic M, Marchi M, Marcuzzo S, Lombardi R, Faber C, Lauria G
Mol Ther Methods Clin Dev. 2023; 31:101116.
PMID: 37808256
PMC: 10550798.
DOI: 10.1016/j.omtm.2023.101116.
microRNA sequencing for biomarker detection in the diagnosis, classification and prognosis of Diffuse Large B Cell Lymphoma.
Larrabeiti-Etxebarria A, Bilbao-Aldaiturriaga N, Arzuaga-Mendez J, Martin-Arruti M, Cozzuto L, Gaafar A
Sci Rep. 2023; 13(1):12159.
PMID: 37500691
PMC: 10374576.
DOI: 10.1038/s41598-023-39271-7.
MicroRNAs associated with postoperative outcomes in patients with limited stage neuroendocrine carcinoma of the esophagus.
Okumura T, Fujii T, Terabayashi K, Kojima T, Takeda S, Kashiwada T
Oncol Lett. 2023; 26(1):276.
PMID: 37274462
PMC: 10236049.
DOI: 10.3892/ol.2023.13862.
Looking for Plant microRNAs in Human Blood Samples: Bioinformatics Evidence and Perspectives.
Olmi L, Pepe G, Helmer-Citterich M, Canini A, Gismondi A
Plant Foods Hum Nutr. 2023; 78(2):399-406.
PMID: 37256506
PMC: 10363053.
DOI: 10.1007/s11130-023-01063-9.
Strategies for data normalization and missing data imputation and consequences for potential diagnostic microRNA biomarkers in epithelial ovarian cancer.
Lopacinska-Jorgensen J, Petersen P, Oliveira D, Hogdall C, Hogdall E
PLoS One. 2023; 18(5):e0282576.
PMID: 37141239
PMC: 10159121.
DOI: 10.1371/journal.pone.0282576.
Novel device for dividing core needle biopsy specimens to provide paired mirror image-like tissues for genetic and pathological tests.
Nakamura Y, Tsuji K, Shiraishi T, Sako S, Ogura R, Taga H
Sci Rep. 2023; 13(1):6610.
PMID: 37095303
PMC: 10126131.
DOI: 10.1038/s41598-023-33776-x.
Clinical Importance of the lncRNA NEAT1 in Cancer Patients Treated with Immune Checkpoint Inhibitors.
Toker J, Iorgulescu J, Ling A, Villa G, Gadet J, Parida L
Clin Cancer Res. 2023; 29(12):2226-2238.
PMID: 37053197
PMC: 10330151.
DOI: 10.1158/1078-0432.CCR-22-3714.
MicroRNAs: emerging biomarkers and therapeutic targets of bone fragility in chronic kidney disease.
Smout D, Van Craenenbroeck A, Jorgensen H, Evenepoel P
Clin Kidney J. 2023; 16(3):408-421.
PMID: 36865016
PMC: 9972833.
DOI: 10.1093/ckj/sfac219.
Expression of Selected miRNAs in Normal and Cancer-Associated Fibroblasts and in BxPc3 and MIA PaCa-2 Cell Lines of Pancreatic Ductal Adenocarcinoma.
Mandys V, Popov A, Gurlich R, Havranek J, Pfeiferova L, Kolar M
Int J Mol Sci. 2023; 24(4).
PMID: 36835029
PMC: 9961675.
DOI: 10.3390/ijms24043617.